Kymera Therapeutics (KYMR) Market Cap 2020–2026

As of October 29, 2026, Kymera Therapeutics had a market cap of $10.15 billion, which increased by 0.10% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Kymera Therapeutics logo

Kymera Therapeutics, Inc. (KYMR)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$10.15B ▲ 0.10%
Start of 2026
$5.598B ▲ 81.31%
1 Year Ago
$4.408B ▲ 130.27%
All-Time High
$10.54B ▼ 3.70%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Kymera Therapeutics Market Cap History by Year and Month

Kymera Therapeutics Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$10.15B▲ 81.31%
$10.15B▲ 9.67%
$9.255B▼ 5.91%
$9.836B▲ 15.74%
$8.498B▼ 9.83%
$9.424B▲ 40.72%
$6.697B▲ 1.18%
$6.619B▼ 2.66%
$6.8B▲ 3.45%
$6.573B▲ 25.68%
$5.23B▼ 6.57%
2025$5.598B▲ 114.40%
2024$2.611B▲ 84.78%
2023$1.413B▲ 3.21%
2022$1.369B▼ 58.16%
All market cap values reflect closing prices for the period shown.

📊 Kymera Therapeutics Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:

  1. $14.96B
  2. $14.87B
  3. $13.81B
  4. $12.85B
  5. $11.13B
  6. $10.21B
  7. $10.15B
  8. $9.97B
  9. $9.61B
  10. $9.34B
  11. $9.07B
  12. $8.79B
  13. $8.54B
  14. $8.06B
  15. $7.35B
  16. $7.1B
  17. $6.41B
  18. $5.49B
  19. $5.37B
  20. $5.25B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.